Although discussion continues about whether PD-L1 tumor expression evaluation is a useful predictive biomarker in response to PD-1/PD-L1 inhibitors, several recent studies in humans and dogs have corroborated its use [46,68,69,70]. Here, CD274 is linked to neoplasm.